Because of near universal recommendation for annual vaccination (all aged 6 months) only observational studies of influenza vaccine effectiveness can be performed for ethical reasons. However, results from observational studies may be subject to unrecognized selection biases, and study design strategies to identify and adjust for these biases are necessary. We propose estimation of influenza vaccine effectiveness in preventing medically attended influenza in two health systems, and influenza of all severities in a cohort of households with children, in Michigan. We will conduct surveillance at multiple outpatient health centers, three hospitals, and in ~300 enrolled households during the influenza season, and will enroll adult and pediatric patients and household members meeting various case definitions. Vaccination status will be reported and validated, and considered with laboratory-confirmed influenza outcomes to estimate vaccine effectiveness separately for ambulatory, inpatient and household populations, with estimates compared across studies. Analyses will use a test-negative control approach-those testing positive for influenza are cases, those testing negative are controls. Modifiers and confounders of vaccine effectiveness such as age, health status, household size and composition, health care utilization, subjective socio-economic status, and health system characteristics will be assessed and considered in analytic models.
MFIVE-HIVE combined Annual estimation of influenza vaccine effectiveness is necessary to guide vaccination and control policy. We propose estimation of influenza vaccine effectiveness in preventing medically attended influenza among patients in two health systems, and influenza of all severities in a cohort of households with children, in Michigan. Laboratory confirmed influenza outcomes and verified influenza vaccination status will be used to calculate vaccine effectiveness using a test- negative control approach.
|Jackson, Michael L; Chung, Jessie R; Jackson, Lisa A et al. (2017) Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season. N Engl J Med 377:534-543|
|Ohmit, Suzanne E; Petrie, Joshua G; Malosh, Ryan E et al. (2016) Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated. J Infect Dis 213:1229-36|
|Spencer, Sarah; Chung, Jessie; Thompson, Mark et al. (2016) Factors associated with real-time RT-PCR cycle threshold values among medically attended influenza episodes. J Med Virol 88:719-23|
|Petrie, Joshua G; Cheng, Caroline; Malosh, Ryan E et al. (2016) Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013. Clin Infect Dis 62:448-455|
|Zimmerman, Richard K; Balasubramani, G K; Nowalk, Mary Patricia et al. (2016) Classification and Regression Tree (CART) analysis to predict influenza in primary care patients. BMC Infect Dis 16:503|
|Thompson, Mark G; Clippard, Jessie; Petrie, Joshua G et al. (2016) Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses. Pediatr Infect Dis J 35:299-308|
|Petrie, Joshua G; Parkhouse, Kaela; Ohmit, Suzanne E et al. (2016) Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains. J Infect Dis 214:1947-1951|
|Flannery, Brendan; Zimmerman, Richard K; Gubareva, Larisa V et al. (2016) Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. J Infect Dis 214:1010-9|
|Chung, Jessie R; Flannery, Brendan; Thompson, Mark G et al. (2016) Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine. Pediatrics 137:e20153279|
|Zimmerman, Richard K; Nowalk, Mary Patricia; Chung, Jessie et al. (2016) 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type. Clin Infect Dis 63:1564-1573|
Showing the most recent 10 out of 17 publications